Synapse - Works

Results (2639)

Brentuximab vedotin administered before, during, and after multi-agent chemotherapy in patients (pts) with newly-diagnosed CD30+ mature T- and NK-cell lymphomas

Meeting Abstract

Fanale, M. A.; Horwitz, S. M.; Forero-Torres, A.; Bartlett, N. L.; Advani, R. H.; Pro, B.; Chen, R.; Davies, A.; Illidge, T.; Huebner, D.; more...
Blood (2013)

Fulltext@MSK | Save

PET compared with CT as a prognosticator after rituximab induction therapy in follicular lymphoma: Report from the National Lymphocare Study

Meeting Abstract

Wong-Sefidan, I.; Byrtek, M.; Zhou, X.; Friedberg, J. W.; Flowers, C.; Link, B. K.; Zelenetz, A. D.; Dawson, K. L.; Reid, E. G.
Blood (2013)

Fulltext@MSK | Save

Analysis of peripheral T-cell lymphoma (PTCL) subtype by race and geography using the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) dataset

Meeting Abstract

Carson, K. R.; Foss, F. M.; Pinter-Brown, L.; Horwitz, S. M.; Rosen, S. T.; Pro, B.; Federico, M.; Gisselbrecht, C.; Hsi, E. D.
Blood (2013)

Fulltext@MSK | Save

A first-in-man phase 1 study of CUDC-907, a first-in-class chemically-designed dual inhibitor of PI3K and HDAC in patients with refractory or relapsed lymphoma and multiple myeloma

Meeting Abstract

Younes, A.; Flinn, I. W.; Oki, Y.; Copland, A.; Fattaey, A.; Lai, C. J.; Laliberte, R.; Voi, M.; Berdeja, J. G.
Blood (2013)

Fulltext@MSK | Save

Characterizing the CpG methylation of Epstein-Barr virus DNA in the plasma of patients with Hodgkin lymphoma and HIV-associated Burkitt lymphoma

Meeting Abstract

Kanakry, J. A.; Shamay, M.; Kasamon, Y. L.; Li, H.; Gascoyne, R. D.; Gordon, L. I.; Noy, A.; Cesarman, E.; Lee, J. Y.; Horning, S. J.; more...
Blood (2013)

Fulltext@MSK | Save

Cross-platform assessment of genomic imbalance in diffuse large B-cell lymphoma identifies novel candidate loci and genes with prognostic value and roles in lymphomagenesis

Meeting Abstract

Dias, L.; Thodima, V.; Mendiratta, G.; Asha, G.; Gonzalez, C.; Maragulia, J. C.; Zelenetz, A. D.; Feldstein, J. T.; Chaganti, R. S. K.; Houldsworth, J.
Blood (2013)

Fulltext@MSK | Save

Romidepsin is effective and well-tolerated in patients >= 60 years old with relapsed or refractory peripheral T-cell lymphoma (PTCL): Analysis from phase 2 trials

Meeting Abstract

Shustov, A. R.; Coiffier, B.; Horwitz, S. M.; Sokol, L.; Pro, B.; Nielsen, T.; Wolfson, J.; Balser, B. E.; Eisch, R.; Popplewell, L.; more...
Blood (2013)

Fulltext@MSK | Save

Combining ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP): Updated results from a phase 1b study in treatment-naïve patients with CD20-positive B-cell non-Hodgkin's lymphoma (NHL)

Meeting Abstract

Younes, A.; Flinn, I.; Berdeja, J.; Friedberg, J. W.; Casulo, C.; Thieblemont, C.; Morschhauser, F.; Westin, J. R.; Seetharam, S.; Hellemans, P.; more...
Blood (2013)

Fulltext@MSK | Save

Safety and efficacy of obinutuzumab (GA101) plus CHOP chemotherapy in first-line advanced diffuse large B-cell lymphoma: Results from the phase 2 gather study (GAO4915g)

Meeting Abstract

Zelenetz, A. D.; Mobasher, M.; Costa, L. J.; Flinn, I.; Flowers, C. R.; Kaminski, M. S.; Sandmann, T.; Trunzer, K.; Vignal, C.; Forero-Torres, A.
Blood (2013)

Fulltext@MSK | Save

A phase I study of an anti-CD30 x anti-CD16A bispecific tandab antibody, AFM13, in patients with relapsed or refractory Hodgkin lymphoma

Meeting Abstract

Zhukovsky, E.; Rothe, A.; von Tresckow, B.; Topp, M.; Younes, A.; Eichenauer, D. A.; Hummel, H.; Reiners, K. S.; Dietlein, M.; Kessler, J.; more...
Blood (2013)

Fulltext@MSK | Save